Revive Therapeutics Stock Return On Asset
| RVVTF Stock | USD 0.01 0.00 0.00% |
Revive Therapeutics fundamentals help investors to digest information that contributes to Revive Therapeutics' financial success or failures. It also enables traders to predict the movement of Revive OTC Stock. The fundamental analysis module provides a way to measure Revive Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revive Therapeutics otc stock.
Revive |
Revive Therapeutics OTC Stock Return On Asset Analysis
Revive Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Revive Therapeutics Return On Asset | -0.43 |
Most of Revive Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revive Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Revive Therapeutics has a Return On Asset of -0.4252. This is 95.14% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Revive Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Revive Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Revive Therapeutics could also be used in its relative valuation, which is a method of valuing Revive Therapeutics by comparing valuation metrics of similar companies.Revive Therapeutics is currently under evaluation in return on asset category among its peers.
Revive Fundamentals
| Return On Equity | -0.83 | |||
| Return On Asset | -0.43 | |||
| Current Valuation | 32.12 M | |||
| Shares Outstanding | 353.56 M | |||
| Shares Owned By Insiders | 2.48 % | |||
| Shares Owned By Institutions | 2.42 % | |||
| Price To Earning | (4.10) X | |||
| Price To Book | 4.00 X | |||
| EBITDA | (17.74 M) | |||
| Net Income | (17.81 M) | |||
| Cash And Equivalents | 5.29 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 60 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (13.06 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 16 | |||
| Beta | -0.0535 | |||
| Market Capitalization | 36.1 M | |||
| Total Asset | 17.07 M | |||
| Retained Earnings | (4.38 M) | |||
| Working Capital | 132 K | |||
| Current Asset | 635 K | |||
| Current Liabilities | 503 K | |||
| Net Asset | 17.07 M |
About Revive Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Revive Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revive Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revive Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Revive OTC Stock
Revive Therapeutics financial ratios help investors to determine whether Revive OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Revive with respect to the benefits of owning Revive Therapeutics security.